DEVIKAL
Business purpose.
Achat et vente, importation et exportation, négoce des dispositifs médicaux, commercialisation et distribution de ces marchandises, et toute activité connexe, Toutes prestations de conseils, d'études, d'audit et d'accompagnement en stratégie, organisation, gestion, développement international et marketing, de la conception à la mise en œuvre, ainsi que toute opération ou prestation se rattachant directement ou indirectement à l'objet social.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Wholesale (intercompany trade) of pharmaceutical goods (46.46Z)
- Sector
- Wholesale trade, except of motor vehicles and motorcycles
- Headcount
- Headcount unknown
- Created
- 31 Mar 2022
- Share capital
- 1,000.00 EUR
- Registered with the trade register
- 14 Apr 2022
- Financial year end
- 31/12
- Establishments
- 2
Directors
- ABA TECHNOLOGY President de SAS
Establishments
-
91250815700019 75008 PARIS
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
69 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (4.5 years)
- 9.1 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Legal notices
-
Amendment 23 Nov 2023
- Court :
- Greffe du Tribunal de Commerce de Paris
- Amendment :
- modification survenue sur l'adresse du siège et l'adresse de l'établissement
BODACC B n 20230226, annonce n 3679 · Proof of publication (PDF)
-
Incorporation 24 Apr 2022
- Court :
- Greffe du Tribunal de Commerce de Paris
BODACC A n 20220080, annonce n 1153 · Proof of publication (PDF)
Change history
- officer_appointed (empty) → President de SAS 9 Oct 2026
- registered_address (empty) → 93 boulevard Haussmann 75008 Paris 1 Oct 2026
- capital (empty) → 1000.00 1 Oct 2026